Ognjen Gajic, M.D.

The purpose of this study is to establish the effectiveness of a combination of an inhaled corticosteroid and a beta agonist compared to placebo for the prevention of acute respiratory failure (ARF) in hospitalized patients with pneumonia and hypoxemia.

The purpose of this study is to assess the feasibility, reliability and validity of oxygen supplementation duration as an intermediate outcome of resolution of acute hypoxic respiratory failure from all cause in comparison with PaO2/FiO2, SaO2/FiO2 ratio, and lung injury score trajectories in critically ill patients with acute respiratory failure.

The purpose of this study is to establish the effectiveness of a combination of an inhaled corticosteroid and a beta agonist compared to placebo for the prevention of acute respiratory failure (ARF) in hospitalized patients with pneumonia and hypoxemia.

The purpose of this study is to develop, in close collaboration with stakeholders, an evidence-based decision aid for patients with acute respiratory failure.  To evaluate the impact of the decision aid on patient-important outcomes. We will conduct a prospective trial assessing the impact of the decision aid (vs. usual specialist care) on patient knowledge, patient involvement in decision-making, decision quality, treatment choice, and patient outcomes.

The main objective of this study is to determine the effectiveness of CERTAIN tool to facilitate data processing, support time sensitive clinical decision making and care implementation in patient with common acute medical and surgical syndromes when compared with current, largely unstructured approach.

The purpose of this study is to raise awareness of and actively address patient physical mobilization needs throughout admission to the ICU, and assess the impact this has on patient quality of care.

The investigators would like to determine if early administration of oral Midodrine in participants diagnosed with sepsis will impact blood pressures and decrease the need for and/or doses of intravenous pressor agents.